A pharmaceutical company has announced that it secured tentative approval from the United States Food and Drug Administration (USFDA) for... Read more
Category: Uncategorized
Major Pharmaceutical Group Acquires Preclinical Cancer Asset
In light of substantial recent investments in oncology and mounting competition, a leading pharmaceutical corporation is seeking a new approach... Read more
Novel Immunotherapy Regimen Approved for Early-Stage Gastric Cancer
The U.S. Food and Drug Administration (FDA) has granted approval for the use of Durvalumab (an immunotherapy) in combination with... Read more
Expedited Review Sought for New Higher-Dose Obesity Treatment
A pharmaceutical corporation has submitted a supplemental application for a higher dose semaglutide injectable (7.2 mg) to the U.S. Food... Read more
Global Strategic Restructuring: A Major Pharma Group’s Shift Toward Automation and Production Reallocation
The recent decisions by a leading Swiss pharmaceutical group highlight a broader trend within the industry: prioritizing automation, advanced manufacturing... Read more
Cost-Effective Solution for Retinal Diseases Enters European Market
On November 24, 2025, in Basel, Sandoz, a global leader in affordable medicines, announced the European launch of Afqlir® (aflibercept).... Read more
Investigating Antibiotic Strategies to Address a Global Health Challenge
Antimicrobial Resistance (AMR) is emerging as a critical worldwide public health threat, with the potential to cause at least 10... Read more
HCMC University Medical Centre and Novartis Strengthen Medical Collaboration
On November 19, in Ho Chi Minh City, the University Medical Centre of Hồ Chí Minh City (UMC) and Novartis... Read more
Vietnam’s Healthcare Sector on the Verge of a Breakthrough: Expectations for Digital Transformation
At the 23rd Annual Scientific Conference of the Southern Region Hospital Directors Club, delegates focused their discussions on digital transformation,... Read more









